Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)Application
Figure 2:Western blot analysis using PRKAA2 mAb against human PRKAA2 (AA: 453-552) recombinant protein. (Expected MW is 36.7 kDa)Application
Figure 3:Western blot analysis using PRKAA2 mAb against HEK293 (1) and PRKAA2 (AA: 453-552)-hIgGFc transfected HEK293 (2) cell lysate.Application
Figure 4:Immunohistochemical analysis of paraffin-embedded esophageal cancer tissues using PRKAA2 mouse mAb with DAB staining.Application
Figure 5:Immunohistochemical analysis of paraffin-embedded rectum cancer tissues using PRKAA2 mouse mAb with DAB staining.| Product Name | PRKAA2 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | AMPK; AMPK2; PRKAA; AMPKa2 |
| Immunogen | Purified recombinant fragment of human PRKAA2 (AA: 453-552) expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | WBIHCICC/IF |
| WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | Human |
| Alternative Names | AMPK AMPK2 PRKAA AMPKa2 |
|---|---|
| Molecular Weight(MW) | 62.3kDa |
| Entrez Gene | 5563 |
|---|
Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Application
Figure 2:Western blot analysis using PRKAA2 mAb against human PRKAA2 (AA: 453-552) recombinant protein. (Expected MW is 36.7 kDa)
Application
Figure 3:Western blot analysis using PRKAA2 mAb against HEK293 (1) and PRKAA2 (AA: 453-552)-hIgGFc transfected HEK293 (2) cell lysate.
Application
Figure 4:Immunohistochemical analysis of paraffin-embedded esophageal cancer tissues using PRKAA2 mouse mAb with DAB staining.
Application
Figure 5:Immunohistochemical analysis of paraffin-embedded rectum cancer tissues using PRKAA2 mouse mAb with DAB staining.| Application Notes | WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Purified antibody in PBS with 0.05% sodium azide |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
